| Cash Flow | 2025-09-30 |
|---|---|
| Net loss | -40,067,076 |
| Equity-based compensation | 18,824,215 |
| Amortization of right-of-use assets | 295,576 |
| Depreciation | 355,162 |
| Changes in fair value of contingent liability | 1,207,500 |
| Prepaid expenses | 68,914 |
| Deposits | 284,000 |
| Accounts receivable | 250,000 |
| Accounts payable and accrued liabilities | 553,115 |
| Due to related parties | -25,000 |
| Lease liabilities | -162,541 |
| Net cash used in operating activities | -19,621,963 |
| In-process research and development | 9,075,045 |
| Additions to property, plant and equipment | 8,449,332 |
| Net cash used in investing activities | -17,524,377 |
| Proceeds from common stock issuances | 206,400,015 |
| Offering costs | 15,076,556 |
| Proceeds from exercise of warrants | 18,476,176 |
| Proceeds from exercise of stock options | 2,404,500 |
| Payment of deferred offering costs | 300,000 |
| Net cash provided by financing activities | 211,904,135 |
| Net increase in cash | 174,757,795 |
| Cash and cash equivalents at beginning of period | 28,507,257 |
| Cash and cash equivalents at end of period | 203,265,052 |
Nano Nuclear Energy Inc. (NNE)
Nano Nuclear Energy Inc. (NNE)